hydralazine has been researched along with Multiple Organ Failure in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HC | 1 |
| Hsiao, TS | 1 |
| Liao, MH | 1 |
| Tsao, CM | 1 |
| Shih, CC | 1 |
| Wu, CC | 1 |
1 other study available for hydralazine and Multiple Organ Failure
| Article | Year |
|---|---|
Low-dose hydralazine improves endotoxin-induced coagulopathy and multiple organ dysfunction via its anti-inflammatory and anti-oxidative/nitrosative properties.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta, Thoracic; Blood Coagulation Disorders; Blood | 2020 |